Artificial valve device

By using shrinkable and self-expandable braided threads cross-weaving anchoring scaffolds and biocompatible polymer membranes in the prosthetic valve device, the lax sealing and unstable anchoring of the prosthetic valves in the prior art are solved. Problem, achieving better adaptability and stability, reducing the risk of blood leakage and ventricular outflow tract obstruction.

CN222055685UActive Publication Date: 2024-11-26SHANGHAI CONFLOW MEDTECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202322946975.0
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-11-01
Publication Date
2024-11-26
Estimated Expiration
2033-11-01

AI Technical Summary

Technical Problem

When implanted into the human heart, existing artificial valve devices are prone to problems such as lax sealing, unstable anchoring, risk of displacement, and obstruction of the ventricular outflow tract. Especially in places where calcification or lack of plaques are difficult to properly anchor, resulting in blood leakage. Leakage and cardiac efficiency decrease.

Method used

An anchoring bracket formed by cross-weaving of shrinkable and self-expandable braided wires, combined with a biocompatible polymer membrane and a hollow mesh structure, is fixed by mechanical connection and suture to form a flexible anchoring structure. To adapt to the D-shaped annulus, reduce the impact of radial forces on the heart tissue, and connect it with the mounting bracket through the protrusion to ensure that the prosthetic valve operates stably away from the stressed area.

Benefits of technology

It improves the anchoring stability and sealing of the prosthetic valve, reduces perival leakage and ventricular outflow tract obstruction, adapts to special anatomical structure, extends the service life of the prosthetic valve and improves hemodynamic function.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222055685U_ABST
    Figure CN222055685U_ABST
Patent Text Reader

Abstract

A prosthetic valve device comprising: a prosthetic valve (101); a mounting bracket (102), wherein the artificial valve is mounted on the mounting bracket (102); an anchoring bracket (103) comprising: a lower disk part (1031); an upper disc part (1033); an intermediate columnar part (1032), both ends of which are respectively connected to the lower disc part (1031) and the upper disc part (1033); and the protruding part (1034) protrudes from the upper disc part (1033) away from the middle columnar part (1032), and the protruding part (1034) is connected with one end part of the mounting bracket (102).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical devices, in particular to an artificial valve device. Background Art

[0002] Valvular disease is a common cardiovascular disease, including deformities, valvular stenosis, calcification, insufficiency and regurgitation caused by congenital dysplasia or acquired diseases and aging. These valvular diseases change the normal flow of blood and cause a series of symptoms, such as palpitations, shortness of breath, fatigue, edema, angina, syncope, etc. after activities. In particular, calcification, narrowing, insufficiency and regurgitation of the mitral valve are common valvular diseases. In valve replacement surgery, a valve prosthesis is added to the mitral valve that cannot work properly to replace the native mitral valve of the human body to treat or improve the narrowing and regurgitation caused by native mitral valve disease. Prosthetic heart valves that can be contracted to a relatively small circumferential size can be delivered to the patient's body less invasively than non-contractible valves. For example, a contractible valve prosthesis and its components can be delivered to the patient's body via a tubular delivery device such as a catheter, a cannula, a laparoscopic instrument, etc. This catheter-deliverable valve prosthesis could avoid more invasive procedures such as full-thorax, open-heart surgery.

[0003] In order to deliver the valve prosthesis that can be delivered via a catheter to the original valve position of the human body to replace the original mitral valve of the human body, the artificial valve device is usually composed of three parts, an artificial valve, a valve mounting bracket and a valve anchoring bracket. The valve mounting bracket and the valve anchoring bracket can be an integrated bracket structure or a bracket structure formed by separate combinations. In order to put the artificial valve into the delivery device and finally into the patient's body, the valve must first shrink or curl with the valve mounting bracket to reduce its circumferential size. The artificial valve usually takes the form of a valve structure installed on an expandable and retractable valve mounting bracket. The valve is usually installed on two types of brackets: a self-expanding bracket and a balloon expandable bracket. In addition, in order to fix the valve structure at the original valve position of the human body, a valve anchoring bracket is usually required. The valve anchoring bracket is usually composed of a retractable and self-expandable bracket structure, which is unfolded or released via a delivery catheter device and re-expanded to a full operating size at or near the annular gap where the patient's heart valve will be replaced by a prosthetic valve. When currently available valve prostheses are implanted in the human heart, they often have paravalvular leakage caused by poor sealing and unstable anchoring, and are prone to displacement, which reduces the therapeutic effect of the lesion. At the same time, limited by the influence of anatomical structures near the heart valve, such as anatomical structures such as the aortic outflow tract, artificial valve devices are prone to ventricular outflow tract obstruction and other problems. Although various improvements have been made to collapsible prosthetic heart valves, traditional devices, systems and methods still have some defects. In traditional retractable and expandable heart valves, the anchoring stent is usually anchored in the natural valve ring by expanding so that the stent body exerts a radial force on the natural valve ring. If the radial force is too large, it may cause damage to the heart tissue. On the contrary, if the radial force is too small, the heart valve can move from its implantation position, for example, move into the left ventricle, which requires emergency surgery to remove the displaced valve. Because this radial force anchoring mechanism depends on the presence of calcification or plaque in the natural valve ring, it is difficult to properly anchor the valve in a location lacking plaque (such as the mitral valve ring). In addition, in some cases, due to uneven calcification and irregularities in the native valve annulus, blood may leak around the artificial heart valve in what is known as paravalvular leakage. This leakage allows blood to flow from the left ventricle back into the left atrium, reducing heart efficiency and placing greater strain on the myocardium. Moreover, in certain applications, such as mitral valve replacement, an artificial heart valve device may require a lower profile so as not to interfere with surrounding tissue structures. Such a low profile makes it difficult for the artificial valve structure to remain stable. In view of the foregoing, there is a need for further improvements in devices for anchoring of prosthetic heart valve implants and collapsible prosthetic heart valve devices, particularly self-expanding prosthetic heart valves. Utility Model Content

[0004] In view of this, the utility model provides an artificial valve device, an artificial valve device, comprising: an artificial valve; a mounting bracket, the artificial valve is mounted on the mounting bracket; an anchoring bracket, the anchoring bracket comprising: a lower plate portion; an upper plate portion; an intermediate columnar portion, both ends of which are respectively connected to the lower plate portion and the upper plate portion; a protrusion, which protrudes from the upper plate portion away from the intermediate columnar portion, and the protrusion is connected to one end portion of the mounting bracket.

[0005] According to one aspect of the aforementioned technical solution of the utility model, the anchoring stent is formed by cross-braiding contractible and self-expandable braided wires.

[0006] According to one aspect of the aforementioned technical solution of the utility model, the disk diameter of the upper disk portion is greater than the disk diameter of the lower disk portion.

[0007] According to one aspect of the aforementioned technical solution of the utility model, the disk surface of the upper disk portion is inclined at an angle to the axis of the middle columnar portion.

[0008] According to one aspect of the aforementioned technical solution of the utility model, the protrusion of the anchoring bracket is connected to one end of the mounting bracket by a mechanical connection.

[0009] According to one aspect of the aforementioned technical solution of the utility model, the mechanical connection method includes suturing and fixing.

[0010] According to one aspect of the aforementioned technical solution of the utility model, the inner surface or outer surface of the mounting bracket and the anchoring bracket is provided with a biocompatible polymer film.

[0011] According to one aspect of the aforementioned technical solution of the utility model, the mounting bracket is a columnar cylinder with a hollow mesh structure, and the columnar cylinder is formed by laser cutting of a metal pipe with a shape memory effect.

[0012] According to one aspect of the aforementioned technical solution of the utility model, the artificial valve is installed inside the self-expandable mounting bracket, and the artificial valve can be loaded into the catheter delivery device as the mounting bracket shrinks or curls to reduce its circumferential size.

[0013] According to one aspect of the aforementioned technical solution of the utility model, the artificial valve and its mounting bracket form a valve structure that can control the unidirectional flow of fluid, and the valve structure is arranged inside the anchoring bracket.

[0014] According to one aspect of the aforementioned technical solution of the utility model, the artificial valve is a biological valve made of bovine pericardium.

[0015] According to one aspect of the aforementioned technical solution of the utility model, the artificial valve is an artificial valve including three leaflets or more leaflets.

[0016] Because the braided anchoring stent is flexible, it can better adapt to the special D-shaped valve ring structure and prevent paravalvular leakage. The two discs of the anchoring stent can better fit the valve ring structure, relying on radial force to press against the atrial and ventricular walls to provide stable anchoring. At the same time, the braided flexible disc can better adapt to the special anatomical structure, and the excessive radial force will not affect the contraction and relaxation of the valve ring. In addition, the anchoring stent is connected to the mounting stent by means of the protrusion, so that the artificial valve can be conveniently set away from the stress deformation area, so that the artificial valve can better operate as expected.

[0017] In addition, the special anchoring stent protrusion can shorten the distance between the two disc surfaces to prevent affecting the adjacent anatomical structures at the setting location, such as outflow tract obstruction, while ensuring that the stent is installed at an appropriate length to facilitate better suturing of the artificial valve, prevent the artificial valve from being sutured too short and affecting the hemodynamic function of the artificial valve, and prevent the artificial valve from failing prematurely.

[0018] In addition, since the disk diameter of the upper disk portion on the atrial side is larger than the disk diameter of the lower disk portion on the ventricular side and the disk surface of the upper disk portion on the atrial side is inclined at an angle to the axis of the middle columnar portion, it helps to more conveniently fix the artificial valve device at the target position of the heart (such as the atrium and ventricle) or release it from the target position of the heart.

[0019] Furthermore, since the inner surface or outer surface of the mounting stent and the anchoring stent is sutured with a biocompatible polymer film, sealing can be ensured and paravalvular leakage can be prevented.

[0020] In general, the artificial valve device of the present invention is flexible and can therefore better adapt to the special D-shaped valve ring structure and prevent paravalvular leakage. Its structure can also position the artificial valve away from the stress-bearing area so that the artificial valve can function better. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 is a three-dimensional exploded view of an artificial valve device according to the utility model;

[0022] Figure 2 is a side exploded view of an artificial valve device according to the utility model, showing the valve structure;

[0023] Figure 3 It is a detailed structural diagram of the anchor bracket according to the utility model;

[0024] Figure 4 This is a state diagram of the anchoring stent according to the present invention when installed on the heart.

[0025] It should be understood that the accompanying drawings are not necessarily drawn to scale, and some parts may be exaggerated to highlight the structural details of the present invention. Detailed Embodiments

[0026] The following will describe various specific embodiments of the present invention with reference to the accompanying drawings that form a part of this specification. It should be understood that although various terms indicating directions, such as "front", "rear", "upper", "lower", "left", "right", "top", "bottom", etc., are used in the present invention to describe various exemplary structural parts and components of the present invention, these terms are used herein only for the purpose of convenience of description and are determined based on the exemplary orientations shown in the accompanying drawings. Since the embodiments in the present invention can be arranged in different directions, these terms indicating directions are only for illustration and do not constitute a limitation.

[0027] As Figure 1 and Figure 2 shown, the artificial valve device generally has a "plus" - shaped structure. The "plus" - shaped structure facilitates its installation at the target position in the heart and proper cooperation with the atrial and ventricular structures. The artificial valve device can be a valve prosthesis delivered via a catheter to the position of the native valve in the human body to replace the native mitral valve. The artificial valve device includes an artificial valve 101, a mounting stent 102, and an anchoring stent 103. The artificial valve can be a three - leaf or multi - leaf valve. The three - leaf or multi - leaf artificial valve 101 is sutured and installed inside the mounting stent. The mounting stent 102 can be laser - cut from a metal pipe with a shape - memory alloy effect, thus having a columnar structure feature with hollow mesh holes. The mounting stent 102 can expand or contract by itself. Therefore, the artificial valve 101 can reduce its circumferential dimension as the mounting stent 102 contracts or curls, so that it can be loaded into the catheter delivery device and delivered to the target position. The metal pipe made of shape - memory alloy can change the shape of the mounting stent 102 under specific conditions to adapt to artificial valves with different structures. The artificial valve 101 and its mounting stent 102 form a valve structure 104 that can control the one - way flow of fluid. This valve structure is arranged inside the anchoring stent 103 and is fixed at the position of the native valve in the human body through the anchoring stent 103.

[0028] As Figure 3As shown, the anchoring stent 103 is composed of a coiled frame stent structure formed by cross-weaving of contractible and self-expandable braided wires. The anchoring stent 103 includes: a lower disc portion 1031, which can be arranged at the outflow end or at the ventricle side; an upper disc portion 1033, which can be arranged at the inflow end or at the atrial side; an intermediate columnar portion 1032, whose two ends are respectively connected to the lower disc portion 1031 and the upper disc portion 1033; and a protrusion 1034, which protrudes from the upper disc portion 1033 away from the intermediate columnar portion 1032. Although the above-mentioned specific structure of the anchoring stent 103 is given, it can be understood that the anchoring stent 103 can also adopt different structures according to specific circumstances. As shown in the figure, the diameter of the upper disk portion 1033 on the atrial side is larger than the diameter of the lower disk portion 1031 on the ventricular side, and the disk surface of the upper disk portion 1033 on the atrial side is inclined at an angle to the axis of the middle columnar portion 1032, so as to facilitate fixing the artificial valve device at the target position of the atrium and ventricle or releasing it from the target position of the atrium and ventricle. Of course, this is not necessary. In other embodiments, the diameter of the upper disk portion 1033 may also be smaller than the diameter of the lower disk portion 1031, such as in an inverted structure, and the disk surface of the upper disk portion 1033 on the atrial side may also be set to be perpendicular to the axis of the middle columnar portion 1032. One end of both sides of the anchoring bracket 103 formed by cross-weaving of braided wires is connected to one end of the internal mounting bracket 102 by, for example, a mechanical connection method, which may be suturing fixation. Of course, in addition to suturing fixation, the mechanical connection method may also be inlaying, riveting, or sleeve interference fit. Figure 3 As shown, an end connection portion 1035 is provided at the upper end of the protrusion 1034 to achieve connection with the internal mounting bracket 102. The inner surface or outer surface of the mounting bracket 102 and the anchoring bracket 103 is sutured with a biocompatible polymer film to ensure sealing and prevent paravalvular leakage. Of course, other forms of films or structures can also be provided on the inner surface or outer surface of the mounting bracket 102 and the anchoring bracket 103.

[0029] After delivery, the prosthetic valve device is deployed or released via the delivery catheter device and re-expanded to full operational size at or near the annulus of the patient's heart valve to be replaced by the prosthetic valve device. Figure 4As shown, the upper disc portion 1033 rests on the inner wall with reduced diameter on the lower side of the atrium, the lower disc portion 1031 rests on the inner wall of the ventricle, and the middle columnar portion 1032 rests on the valve ring through radial support force, thereby fixing the artificial valve device in place. In general, the fixing method includes two methods: the transapical approach and the transfemoral vein-atrial septal approach. When the transapical approach is adopted, after the artificial valve device reaches the target position, the upper disc portion 1033 is first released at the valve ring position, and then the lower disc portion 1031 is released. The upper disc portion 1033 and the lower disc portion 1031 are respectively pressed against the atrium and ventricle walls by the radial support force of the disc portion, and the middle columnar portion 1032 is pressed against the valve ring position by radial support force. When delivered via the transfemoral vein-septal approach, the lower disc portion 1031 is released first, and then the upper disc portion 1033 is released, the prosthetic heart valve device is connected to the delivery device, the delivery device is used to reposition the prosthetic heart valve to the target position, and the prosthetic heart valve is separated from the delivery device after evaluating the functionality of the prosthetic heart valve device.

[0030] Although the utility model has been disclosed in conjunction with the embodiments described above, various alternatives, modifications, changes, improvements and / or substantially equivalent solutions, whether known or foreseeable now or in the future, are obvious to those skilled in the art. In addition, the technical effects and / or technical problems described in this specification are exemplary rather than restrictive, so the disclosure of this specification can be used to solve other technical problems and have other technical effects. Therefore, the embodiments of the utility model stated above are intended to be illustrative rather than restrictive. Various changes can be made without departing from the spirit or scope of the utility model. Therefore, the utility model is intended to include all known or previously developed alternatives, modifications, changes, improvements and / or substantially equivalent solutions.

Claims

1. An artificial valve device, comprising: Prosthetic valves; a mounting bracket, on which the artificial valve is mounted; An anchor bracket comprises: a lower plate portion; an upper plate portion; an intermediate columnar portion, both ends of which are respectively connected to the lower plate portion and the upper plate portion; a protrusion, which protrudes from the upper plate portion away from the intermediate columnar portion, and the protrusion is connected to one end of the mounting bracket.

2. An artificial valve device as described in claim 1, wherein the anchoring stent is formed by cross-weaving of shrinkable and self-expandable braided wires.

3. The artificial valve device of claim 1, wherein a disc diameter of the upper disc portion is greater than a disc diameter of the lower disc portion.

4. The artificial valve device as described in claim 1, wherein the disk surface of the upper disk portion is inclined at an angle to the axis of the middle columnar portion.

5. The artificial valve device according to claim 1, wherein: The protrusion of the anchor bracket is connected to one end of the mounting bracket by a mechanical connection.

6. The artificial valve device according to claim 5, wherein: The mechanical connection method includes suturing and fixing.

7. The artificial valve device according to claim 1, wherein: The inner surface or outer surface of the mounting bracket and the anchoring bracket is provided with a biocompatible polymer film.

8. The artificial valve device according to claim 1, wherein: The mounting bracket is a columnar cylinder with a hollow mesh structure, and the columnar cylinder is formed by laser cutting of a metal pipe with a shape memory effect.

9. The artificial valve device according to claim 1, wherein: The artificial valve is mounted inside the self-expandable mounting stent, and the artificial valve can be loaded into a catheter delivery device as the mounting stent is contracted or curled to reduce its circumferential size.

10. The artificial valve device according to claim 1, wherein: The artificial valve and its mounting bracket form a valve structure capable of controlling the unidirectional flow of fluid, and the valve structure is arranged inside the anchoring bracket.

11. The artificial valve device according to claim 1, wherein: The artificial valve is a biological valve made of bovine pericardium.

12. The artificial valve device according to claim 1, wherein: The artificial valve is an artificial valve including three or more leaflets.